Newsroom
May 26, 2020
SAN ANTONIO (May 26, 2020) — New mothers who have returned to using opioids or have died of an overdose often have a troubled past going back to their childhood. The death of a parent, abuse by a trusted individual, the routine use of drugs in the home or problems with relationships later as an […]
May 22, 2020
Mays Cancer Center experts to discuss why getting screenings now is important during May 29 webinar SAN ANTONIO (May 22, 2020) — Studies have shown that individuals with cancer who get COVID-19 are more likely to have poor outcomes. And with everyone staying home during the pandemic, many people have missed their regular cancer screenings. […]
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
May 13, 2020
Media contact: Rosanne Fohn, (210) 567-3026, fohn@uthscsa.edu SAN ANTONIO (May 11, 2020) — The COVID-19 Infectious Disease team at UT Health San Antonio and University Health System is beginning the second stage of the remdesivir clinical trial, which is being sponsored by the National Institute of Allergy and Infectious Diseases, NIAID. This second phase of […]
May 13, 2020
Asante Sebastian Contreras, age 20, and a student in the Department of Emergency Health Sciences Paramedic Certification Program at UT Health San Antonio, died in a traffic crash on Sunday, May 3, in San Antonio. Contreras worked as an emergency medical technician for an ambulance service in San Antonio and, as a student in the […]
May 4, 2020
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.